GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zealand Pharma AS (STU:22Z) » Definitions » Cyclically Adjusted FCF per Share

Zealand Pharma AS (STU:22Z) Cyclically Adjusted FCF per Share : €-2.01 (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Zealand Pharma AS Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Zealand Pharma AS's adjusted free cash flow per share for the three months ended in Sep. 2024 was €-0.562. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-2.01 for the trailing ten years ended in Sep. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -23.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Zealand Pharma AS was -23.00% per year. The lowest was -32.60% per year. And the median was -27.80% per year.

As of today (2025-01-10), Zealand Pharma AS's current stock price is €97.40. Zealand Pharma AS's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2024 was €-2.01. Zealand Pharma AS's Cyclically Adjusted Price-to-FCF of today is .


Zealand Pharma AS Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Zealand Pharma AS's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zealand Pharma AS Cyclically Adjusted FCF per Share Chart

Zealand Pharma AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.79 -1.00 -1.38 -1.84 -1.88

Zealand Pharma AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.87 -1.88 -1.94 -1.97 -2.01

Competitive Comparison of Zealand Pharma AS's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Zealand Pharma AS's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zealand Pharma AS's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zealand Pharma AS's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Zealand Pharma AS's Cyclically Adjusted Price-to-FCF falls into.



Zealand Pharma AS Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zealand Pharma AS's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.562/118.9000*118.9000
=-0.562

Current CPI (Sep. 2024) = 118.9000.

Zealand Pharma AS Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 -0.224 99.400 -0.268
201503 -0.364 100.200 -0.432
201506 -0.338 100.300 -0.401
201509 -0.362 100.200 -0.430
201512 -0.264 99.800 -0.315
201603 0.232 100.200 0.275
201606 -0.362 100.600 -0.428
201609 -0.259 100.200 -0.307
201612 0.568 100.300 0.673
201703 -0.276 101.200 -0.324
201706 -0.648 101.200 -0.761
201709 0.002 101.800 0.002
201712 -0.458 101.300 -0.538
201803 -0.409 101.700 -0.478
201806 -0.501 102.300 -0.582
201809 -0.464 102.400 -0.539
201812 -0.660 102.100 -0.769
201903 0.211 102.900 0.244
201906 -0.591 102.900 -0.683
201909 -0.671 102.900 -0.775
201912 -0.649 102.900 -0.750
202003 -0.800 103.300 -0.921
202006 -0.404 103.200 -0.465
202009 -0.384 103.500 -0.441
202012 -0.903 103.400 -1.038
202103 -1.188 104.300 -1.354
202106 -1.018 105.000 -1.153
202109 -0.656 105.800 -0.737
202112 -1.009 106.600 -1.125
202203 -0.999 109.900 -1.081
202206 -0.692 113.600 -0.724
202209 -0.367 116.400 -0.375
202212 -0.735 115.900 -0.754
202303 -0.516 117.300 -0.523
202306 -0.412 116.400 -0.421
202309 -0.272 117.400 -0.275
202312 0.113 116.700 0.115
202403 -0.494 118.400 -0.496
202406 -0.507 118.500 -0.509
202409 -0.562 118.900 -0.562

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Zealand Pharma AS  (STU:22Z) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Zealand Pharma AS Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Zealand Pharma AS's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Zealand Pharma AS Business Description

Industry
Traded in Other Exchanges
Address
Sydmarken 11, Soborg, DNK, DK-2860
Zealand Pharma AS is a biotechnology company. It is focused on the discovery, design, and development of peptide-based medicines. The company's product pipeline includes three product candidates in clinical development: glepaglutide, which is being developed to treat short bowel syndrome or SBS; dasiglucagon formulated for use in a dual-hormone artificial pancreas system for diabetes management; and dasiglucagon for use in the treatment of congenital hyperinsulinism. The company has out-licensed a peptide program to Boehringer Ingelheim that has been moved ahead into early clinical development: a once-weekly novel dual-acting GLP-1/glucagon agonist for the treatment of obesity and/or Type 2 diabetes.

Zealand Pharma AS Headlines

No Headlines